RECRUITING

Dose-Response to Resistance Exercise on Cardiovascular Health

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A large body of evidence indicates numerous health benefits of physical activity, including prevention of cardiovascular disease (CVD), the leading cause of death in the US. This evidence has led to US Physical Activity Guidelines that recommend ≥150 min/week of moderate or ≥75 min/week of vigorous aerobic exercise (AE), plus resistance exercise (RE; such as weight lifting) on ≥2 days/week. To date, current research has mostly focused on AE, and we know a great deal about the dose-response relation between AE and health, resulting in clear and practical guidance to the public on the recommended "dose" in min/week. However, currently far less is known about the dose-response for RE: ≥2 days/week are recommended, but with no duration specified. Thus, this project aims to provide clarity on the dose relationship between RE and health. This project will significantly contribute to developing more effective CVD prevention approaches, advancing prescriptive intervention guidelines, by helping to fill the important gaps in knowledge on effective minimum dose, beneficial optimal dose, and safe maximum dose of RE for CVD prevention. Thus, advancing prescriptive intervention guidelines, and provide important insights for future science of physical activity and health.

Official Title

Dose-Response to Resistance Exercise on Cardiovascular Health

Quick Facts

Study Start:2024-10
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06619444

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Non-Smoker
  2. * Overweight or Obese: Body Mass Index 25-43 kg/m2
  3. * Inactive: not meeting the US resistance and aerobic exercise guidelines over the last 6 months
  1. * Unstable coronary heart disease or heart failure
  2. * Uncontrolled arrhythmias or severe aortic stenosis
  3. * Acute myocarditis, endocarditis, or pericarditis
  4. * Cancer, requiring treatment in the past 5 years
  5. * Autoimmune diseases, affecting immune system
  6. * Plans to be away ≥4 weeks in the next 1 year
  7. * Pregnancy/anticipated pregnancy during the study
  8. * Other medical condition that is life-threatening or can interfere with or be aggravated by the exercise training
  9. * Major risk factors for coronary heart disease
  10. * Uncontrolled diabetes or musculoskeletal limitations

Contacts and Locations

Study Contact

Duck-chul Lee, PhD
CONTACT
412-383-4004
dclee@pitt.edu

Principal Investigator

Duck-chul Lee, PhD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh

Study Locations (Sites)

Physical Activity Research Center (PARC)
Pittsburgh, Pennsylvania, 15219
United States

Collaborators and Investigators

Sponsor: University of Pittsburgh

  • Duck-chul Lee, PhD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10
Study Completion Date2027-12

Study Record Updates

Study Start Date2024-10
Study Completion Date2027-12

Terms related to this study

Keywords Provided by Researchers

  • Exercise

Additional Relevant MeSH Terms

  • Cardiovascular Risk